FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1424-1430 November 7, 1996 Number 19 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Valvular heart disease is the most important cardiac manifestation of systemic lupus erythematosus. We performed a study to determine the relation of valvular disease to other clinical features of lupus, whether or not the valve disease progresses, and the associated morbidity and mortality.

Methods We performed transesophageal echocardiography and rheumatologic evaluations in 69 patients with systemic lupus erythematosus. The echocardiographic findings were compared with those in 56 healthy volunteers. Fifty-eight patients (84 percent) had second evaluations a mean (±SD) period of 29±13 months later. The patients and controls were followed for 57 months.

Results Valvular abnormalities were common on the initial and the follow-up echocardiograms (in 61 and 53 percent of the patients, respectively). Valvular thickening was the predominant finding initially and on follow-up (in 51 and 52 percent of the patients, respectively), followed by vegetations (in 43 and 34 percent), valvular regurgitation (in 25 and 28 percent), and stenosis (in 4 and 3 percent). Valvular abnormalities frequently resolved, appeared for the first time, or persisted but changed in appearance or size between the two studies. Mild or moderate valvular regurgitation did not progress to become severe, and new stenoses did not develop. Neither the presence of valvular disease nor changes in the echocardiographic findings were temporally related to the duration, activity, or severity of lupus or to its treatment. The combined incidence of stroke, peripheral embolism, heart failure, infective endocarditis, and the need for valve replacement was 22 percent in the patients with valvular disease, but only 8 percent in those without it. A total of seven patients died during follow-up, in most cases as a result of valvular disease. Valvular abnormalities and complications were uncommon in the controls (occurring in 9 and 2 percent, respectively).

Conclusions Valvular heart disease is common in patients with systemic lupus erythematosus, frequently changes over time, appears to be temporally unrelated to other clinical features of lupus, and is associated with substantial morbidity and mortality.

Source Information

From the University of New Mexico Health Sciences Center and Veterans Affairs Medical Center, Albuquerque.

Address reprint requests to Dr. Roldan at the Cardiology Division, 5B-111, Veterans Affairs Medical Center, 2100 Ridgecrest Dr. SE, Albuquerque, NM 87108.

Full Text of this Article

Related Letters:

Valvular Heart Disease and Systemic Lupus Erythematosus
Piette J.-C., Amoura Z., Papo T., McCarthy G. M., McCarty D. J., Roldan C. A., Crawford M. H.
Extract | Full Text  
N Engl J Med 1997; 336:1324-1325, May 1, 1997. Correspondence

This article has been cited by other articles:

• Saraux, A., Binard, A., Devauchelle-Pensec, V., Jobic, Y., Jousse-Joulin, S. (2008). Right-Sided Native Valve Endocarditis Revealing Adult-Onset Still Disease. ANN INTERN MED 149: 517-519 [Full Text]  
• Roldan, C. A (2008). Valvular and coronary heart disease in systemic inflammatory diseases. Heart 94: 1089-1101 [Full Text]  
• Augoustides, J. G.T., Pochettino, A., Carpenter, J. (2008). Surgical management of thoracoabdominal aortic aneurysm associated with systemic lupus erythematosus. J. Thorac. Cardiovasc. Surg. 136: 215-216 [Full Text]  
• Lonnebakken, M. T., Gerdts, E. (2008). Libman-Sacks endocarditis and cerebral embolization in antiphospholipid syndrome. Eur J Echocardiogr 9: 192-193 [Abstract] [Full Text]  
• Roman, M. J., Salmon, J. E. (2007). Cardiovascular Manifestations of Rheumatologic Diseases. Circulation 116: 2346-2355 [Full Text]  
• Knockaert, D. C. (2007). Cardiac involvement in systemic inflammatory diseases. Eur Heart J 28: 1797-1804 [Abstract] [Full Text]  
• Lockhart, P. B., Loven, B., Brennan, M. T., Fox, P. C. (2007). The evidence base for the efficacy of antibiotic prophylaxis in dental practice. Journal of the American Dental Association 138: 458-474 [Abstract] [Full Text]  
• Doria, A, Iaccarino, L, Sarzi-Puttini, P, Atzeni, F, Turriel, M, Petri, M (2005). Cardiac involvement in systemic lupus erythematosus. Lupus 14: 683-686 [Abstract]  
• Beresford, M W, Cleary, A G, Sills, J A, Couriel, J, Davidson, J E (2005). Cardio-pulmonary involvement in juvenile systemic lupus erythematosus. Lupus 14: 152-158 [Abstract]  
• Lalani, T. A., Kanne, J. P., Hatfield, G. A., Chen, P. (2004). Imaging Findings in Systemic Lupus Erythematosus. RadioGraphics 24: 1069-1086 [Abstract] [Full Text]  
• Codish, S, Liel-Cohen, N, Rovner, M, Sukenik, S, Abu-Shakra, M (2004). Dobutamine stress echocardiography in women with systemic lupus erythematosus: increased occurrence of left ventricular outflow gradient. Lupus 13: 101-104 [Abstract]  
• Morelli, S, Bernardo, M L, Viganego, F, Sgreccia, A, De Marzio, P, Conti, F, Priori, R, Valesini, G (2003). Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus. Lupus 12: 805-812 [Abstract]  
• Lockshin, M, Tenedios, F, Petri, M, McCarty, G, Forastiero, R, Krilis, S, Tincani, A, Erkan, D, Khamashta, M A, Shoenfeld, Y (2003). Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report. Lupus 12: 518-523 [Abstract]  
• Evangelopoulos, M E, Alevizaki, M, Toumanidis, S, Sotou, D, Evangelopoulos, C D, Koutras, D A, Stamatelopoulos, S F, Mavrikakis, M (2003). Mitral valve prolapse in systemic lupus erythematosus patients: clinical and immunological aspects. Lupus 12: 308-311 [Abstract]  
• Jensen-Urstad, K, Svenungsson, E, de Faire, U, Silveira, A, Witztum, J L, Hamsten, A, Frostegard, J (2002). Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease. Lupus 11: 744-752 [Abstract]  
• Jennekens, F. G. I., Kater, L. (2002). The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) 41: 619-630 [Abstract] [Full Text]  
• Al-Abbad, A-J., Cabral, D A, Sanatani, S, Sandor, G G., Seear, M, Petty, R E, Malleson, P N (2001). Echocardiography and pulmonary function testing in childhood onset systemic lupus erythematosus. Lupus 10: 32-37 [Abstract]  
• Turiel, M, Muzzupappa, S, Gottardi, B, Crema, C, Sarzi-Puttini, P, Rossi, E (2000). Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography. Lupus 9: 406-412 [Abstract]  
• Wolak, T, Abu-Shakra, M, Flusser, D, Liel-Cohen, N, Buskila, D, Sukenik, S (2000). Kingella endocarditis and meningitis in a patient with SLE and associated antiphospholipid syndrome. Lupus 9: 393-396 [Abstract]  
• Bijl, M, Brouwer, J, Kallenberg, G G. (2000). Grand Rounds from International Lupus Centres Cardiac abnormalities in SLE: pancarditis. Lupus 9: 236-240 [Abstract]  
• Manzi, S, Kuller, L H, Edmundowicz, D, Sutton-Tyrrell, K (2000). Vascular imaging: changing the face of cardiovascular research. Lupus 9: 176-182 [Abstract]  
• Weiss, B.M, Hess, O.M (2000). Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur Heart J 21: 104-115  
• Whitelaw, D A, Spangenberg, J J, Rickman, R, Hugo, F H, Roberts, M (1999). The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE. Lupus 8: 444-448 [Abstract]  
• Roldan, C. A., Chavez, J., Wiest, P. W., Qualls, C. R., Crawford, M. H. (1998). Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol 32: 1397-1404 [Abstract] [Full Text]  
• Kalke, S, Balakrishanan, C, Mangat, G, Mittal, G, Kumar, N, Joshi, V R (1998). Echocardiography in systemic lupus erythematosus. Lupus 7: 540-544 [Abstract]  
• Specker, C., Perniok, A., Brauckmann, U., Siebler, M., Schneider, M. (1998). Review : Detection of cerebral microemboli in APS-- Introducing a novel investigation method and implications of analogies with carotid artery disease. Lupus 7: S75-S80 [Abstract]  
• Piette, J.-C., Amoura, Z., Papo, T., McCarthy, G. M., McCarty, D. J., Roldan, C. A., Crawford, M. H. (1997). Valvular Heart Disease and Systemic Lupus Erythematosus. NEJM 336: 1324-1325 [Full Text]  
• Specker, C., Rademacher, J., Sohngen, D., Sitzer, M., Janda, I., Siebler, M., Steinmetz, H., Schneider, M. (1997). Cerebral microemboli in patients with antiphospholipid syndrome. Lupus 6: 638-644 [Abstract]